Position in NVAX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$469,784
+$80,660 QoQ
Shares Held
49,871
+4.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,218,616 across 202 Biotechnology names. NVAX ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $469,784 | 49,871 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $389,124 | 47,804 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $330,435 | 49,172 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $480,066 | 55,371 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $386,429 | 61,338 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $242,753 | 37,871 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $326,842 | 40,652 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $571,520 | 45,251 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $501,500 | 39,613 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $223,269 | 46,709 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $235,593 | 49,082 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $333,829 | 46,109 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $320,805 | 43,177 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $235,197 | 33,939 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $273,211 | 26,577 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $578,177 | 31,768 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,631,513 | 31,723 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,342,659 | 31,808 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,555,265 | 38,829 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,381,209 | 30,781 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,503,712 | 25,923 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,872,962 | 21,361 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,418,450 | 30,656 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,452,935 | 22,639 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,257,751 | 15,090 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,300,054 | 95,733 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||